Jiangsu Huachang Chemical Co., Ltd (SHE:002274)
China · Delayed Price · Currency is CNY 6.75
-0.01 (-0.15%)
Apr 30, 2026, 3:04 PM CST
Jiangsu Huachang Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 6,548 | 6,490 | 7,916 | 8,187 | 9,022 | 9,393 |
Other Revenue | 15.51 | 15.51 | 14.3 | 27.43 | 23.31 | 20.72 |
| 6,563 | 6,506 | 7,930 | 8,215 | 9,045 | 9,413 | |
Revenue Growth (YoY) | -15.04% | -17.96% | -3.46% | -9.18% | -3.91% | 54.33% |
Cost of Revenue | 6,257 | 6,225 | 6,847 | 6,779 | 7,425 | 6,872 |
Gross Profit | 305.75 | 280.84 | 1,083 | 1,436 | 1,620 | 2,542 |
Selling, General & Admin | 339.05 | 355.54 | 368.33 | 403.51 | 376.61 | 325.02 |
Research & Development | 75.07 | 83.56 | 89.15 | 101.66 | 58.92 | 63.45 |
Other Operating Expenses | 25.99 | 23.34 | 36.33 | 41.14 | 39.54 | 47.32 |
Operating Expenses | 437.66 | 459.99 | 494.21 | 544.35 | 474.02 | 443.44 |
Operating Income | -131.92 | -179.15 | 588.78 | 891.51 | 1,146 | 2,098 |
Interest Expense | -7.62 | -7.62 | -6.21 | -21.62 | -26.98 | -61.56 |
Interest & Investment Income | 52.08 | 51.03 | 77.9 | 66.45 | 43.92 | 61.23 |
Currency Exchange Gain (Loss) | 3.08 | 3.08 | 1.64 | 3.9 | 7.96 | 7.39 |
Other Non Operating Income (Expenses) | -2.45 | -0.64 | -1.27 | -1.1 | -10.58 | -3.01 |
EBT Excluding Unusual Items | -86.83 | -133.29 | 660.83 | 939.14 | 1,160 | 2,102 |
Gain (Loss) on Sale of Investments | -0.08 | -5.95 | 15.65 | 18.51 | -43.05 | 46.04 |
Gain (Loss) on Sale of Assets | - | - | -0.04 | - | - | - |
Asset Writedown | -175.63 | -159.07 | -9.94 | -13.11 | -42.02 | -22.57 |
Other Unusual Items | 5.4 | 5.4 | 11.04 | 14.42 | 42.03 | 21.1 |
Pretax Income | -257.14 | -292.92 | 677.54 | 958.96 | 1,117 | 2,147 |
Income Tax Expense | -67.9 | -80.37 | 164.09 | 256.98 | 263.29 | 524.05 |
Earnings From Continuing Operations | -189.24 | -212.55 | 513.45 | 701.98 | 853.87 | 1,623 |
Minority Interest in Earnings | 4.77 | 8.21 | 7.93 | 27.7 | 18.25 | 10.51 |
Net Income | -184.47 | -204.34 | 521.37 | 729.68 | 872.11 | 1,633 |
Net Income to Common | -184.47 | -204.34 | 521.37 | 729.68 | 872.11 | 1,633 |
Net Income Growth | - | - | -28.55% | -16.33% | -46.61% | 794.37% |
Shares Outstanding (Basic) | 953 | 952 | 952 | 952 | 952 | 952 |
Shares Outstanding (Diluted) | 953 | 952 | 952 | 952 | 952 | 952 |
Shares Change (YoY) | 0.05% | -0.01% | -0.01% | -0.01% | 0.00% | 0.02% |
EPS (Basic) | -0.19 | -0.21 | 0.55 | 0.77 | 0.92 | 1.72 |
EPS (Diluted) | -0.19 | -0.21 | 0.55 | 0.77 | 0.92 | 1.72 |
EPS Growth | - | - | -28.54% | -16.33% | -46.61% | 794.21% |
Free Cash Flow | -396.63 | -753.01 | 104.64 | 601.7 | 1,173 | 1,597 |
Free Cash Flow Per Share | -0.42 | -0.79 | 0.11 | 0.63 | 1.23 | 1.68 |
Dividend Per Share | 0.100 | 0.100 | 0.300 | 0.300 | 0.300 | 0.300 |
Dividend Growth | -66.67% | -66.67% | - | - | - | 200.00% |
Gross Margin | 4.66% | 4.32% | 13.66% | 17.48% | 17.91% | 27.00% |
Operating Margin | -2.01% | -2.75% | 7.42% | 10.85% | 12.67% | 22.29% |
Profit Margin | -2.81% | -3.14% | 6.58% | 8.88% | 9.64% | 17.35% |
Free Cash Flow Margin | -6.04% | -11.58% | 1.32% | 7.32% | 12.96% | 16.97% |
EBITDA | 323.86 | 281.74 | 1,070 | 1,341 | 1,572 | 2,510 |
EBITDA Margin | 4.93% | 4.33% | 13.49% | 16.32% | 17.38% | 26.66% |
D&A For EBITDA | 455.78 | 460.89 | 481.33 | 449.03 | 425.74 | 411.68 |
EBIT | -131.92 | -179.15 | 588.78 | 891.51 | 1,146 | 2,098 |
EBIT Margin | -2.01% | -2.75% | 7.42% | 10.85% | 12.67% | 22.29% |
Effective Tax Rate | - | - | 24.22% | 26.80% | 23.57% | 24.41% |
Revenue as Reported | 6,506 | 6,506 | 7,930 | 8,215 | 9,045 | 9,413 |
Advertising Expenses | - | 7.16 | 7 | 8.17 | 9.11 | 10.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.